These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 23848972)

  • 1. β-Blockers for the prevention of sudden cardiac death in heart failure patients: a meta-analysis of randomized controlled trials.
    Al-Gobari M; El Khatib C; Pillon F; Gueyffier F
    BMC Cardiovasc Disord; 2013 Jul; 13():52. PubMed ID: 23848972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of drug interventions to prevent sudden cardiac death in patients with heart failure and reduced ejection fraction: an overview of systematic reviews.
    Al-Gobari M; Al-Aqeel S; Gueyffier F; Burnand B
    BMJ Open; 2018 Jul; 8(7):e021108. PubMed ID: 30056380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-adrenergic blocking agents in heart failure: benefits of vasodilating and non-vasodilating agents according to patients' characteristics: a meta-analysis of clinical trials.
    Bonet S; Agustí A; Arnau JM; Vidal X; Diogène E; Galve E; Laporte JR
    Arch Intern Med; 2000 Mar; 160(5):621-7. PubMed ID: 10724047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Aldosterone Antagonists on Sudden Cardiac Death Prevention in Heart Failure and Post-Myocardial Infarction Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Le HH; El-Khatib C; Mombled M; Guitarian F; Al-Gobari M; Fall M; Janiaud P; Marchant I; Cucherat M; Bejan-Angoulvant T; Gueyffier F
    PLoS One; 2016; 11(2):e0145958. PubMed ID: 26891235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical therapy versus implantable cardioverter -defibrillator in preventing sudden cardiac death in patients with left ventricular systolic dysfunction and heart failure: a meta-analysis of > 35,000 patients.
    Peck KY; Lim YZ; Hopper I; Krum H
    Int J Cardiol; 2014 May; 173(2):197-203. PubMed ID: 24636548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No benefits of statins for sudden cardiac death prevention in patients with heart failure and reduced ejection fraction: A meta-analysis of randomized controlled trials.
    Al-Gobari M; Le HH; Fall M; Gueyffier F; Burnand B
    PLoS One; 2017; 12(2):e0171168. PubMed ID: 28166237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of mineralocorticoid receptor antagonists on the risk of sudden cardiac death in patients with heart failure and left-ventricular systolic dysfunction: an individual patient-level meta-analysis of three randomized-controlled trials.
    Rossello X; Ariti C; Pocock SJ; Ferreira JP; Girerd N; McMurray JJV; Van Veldhuisen DJ; Pitt B; Zannad F
    Clin Res Cardiol; 2019 May; 108(5):477-486. PubMed ID: 30264282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of beta-blockers in preventing sudden death in heart failure.
    Teerlink JR; Massie BM
    J Card Fail; 2000 Jun; 6(2 Suppl 1):25-33. PubMed ID: 10908095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perioperative beta-blockers for preventing surgery-related mortality and morbidity.
    Blessberger H; Kammler J; Domanovits H; Schlager O; Wildner B; Azar D; Schillinger M; Wiesbauer F; Steinwender C
    Cochrane Database Syst Rev; 2014 Sep; (9):CD004476. PubMed ID: 25233038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perioperative beta-blockers for preventing surgery-related mortality and morbidity in adults undergoing non-cardiac surgery.
    Blessberger H; Lewis SR; Pritchard MW; Fawcett LJ; Domanovits H; Schlager O; Wildner B; Kammler J; Steinwender C
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD013438. PubMed ID: 31556094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reducing the risk of sudden death in heart failure with beta-blockers.
    Adamson PB; Gilbert EM
    J Card Fail; 2006 Dec; 12(9):734-46. PubMed ID: 17174236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-blockers for hypertension.
    Wiysonge CS; Bradley H; Mayosi BM; Maroney R; Mbewu A; Opie LH; Volmink J
    Cochrane Database Syst Rev; 2007 Jan; (1):CD002003. PubMed ID: 17253471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implantable defibrillators versus medical therapy for cardiac channelopathies.
    McNamara DA; Goldberger JJ; Berendsen MA; Huffman MD
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD011168. PubMed ID: 26445202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-blockers for hypertension.
    Wiysonge CS; Bradley HA; Volmink J; Mayosi BM; Opie LH
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD002003. PubMed ID: 28107561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of sudden cardiac death with beta blockers.
    Hjalmarson A
    Clin Cardiol; 1999 Oct; 22 Suppl 5():V11-5. PubMed ID: 10526698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cause-of-death analysis in patients with cardiac resynchronization therapy with or without a defibrillator: a systematic review and proportional meta-analysis.
    Barra S; Providência R; Duehmke R; Boveda S; Begley D; Grace A; Narayanan K; Tang A; Marijon E; Agarwal S
    Europace; 2018 Mar; 20(3):481-491. PubMed ID: 28666319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefits of β blockers in patients with heart failure and reduced ejection fraction: network meta-analysis.
    Chatterjee S; Biondi-Zoccai G; Abbate A; D'Ascenzo F; Castagno D; Van Tassell B; Mukherjee D; Lichstein E
    BMJ; 2013 Jan; 346():f55. PubMed ID: 23325883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Beginning therapy of heart failure with beta blockers. Do these patients survive longer?].
    MMW Fortschr Med; 2005 Sep; 147(39):10. PubMed ID: 16245769
    [No Abstract]   [Full Text] [Related]  

  • 19. Implantable cardioverter defibrillators. Prophylactic use: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(14):1-74. PubMed ID: 23074465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nurse-led titration of angiotensin converting enzyme inhibitors, beta-adrenergic blocking agents, and angiotensin receptor blockers for people with heart failure with reduced ejection fraction.
    Driscoll A; Currey J; Tonkin A; Krum H
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD009889. PubMed ID: 26689943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.